Inmune Bio (INMB) Non Operating Income (2020 - 2026)
Inmune Bio (INMB) reported Non Operating Income of $203,000 for Q2 2026, up 79.6% from $113,000 a year earlier but down 49.9% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Non Operating Income (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Inmune Bio's Non Operating Income came in at $1.78 million, up 146.7% year-over-year; for FY2025, it was $1.45 million, up 162.2% from FY2024.
- Non Operating Income has a five-year compound annual growth rate of 62.2% (FY2020 to FY2025).
- By year, Non Operating Income came in at $553,000 in FY2024, -$267,000 in FY2023 and -$1.19 million in FY2021.
- Five-year quarterly Non Operating Income spans a low of -$641,000 in Q4 2021 and a high of $961,000 in Q3 2025.
- Year over year, Non Operating Income gained in three of the last five quarters, with growth averaging 120.2%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $405,000 (Q1 2026), $210,000 (Q4 2025) and $961,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Inmune Bio | 53.92 Mn | -38.33 Mn | - | 203,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 203,000.00 |
| Mar 31, 2026 | 405,000.00 |
| Dec 31, 2025 | 210,000.00 |
| Sep 30, 2025 | 961,000.00 |
| Jun 30, 2025 | 113,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 249,000.00 |
| Sep 30, 2024 | 193,000.00 |
| Jun 30, 2024 | 119,000.00 |
| Dec 31, 2023 | -29,000.00 |
| Sep 30, 2023 | -35,000.00 |
| Mar 31, 2022 | -425,000.00 |
| Dec 31, 2021 | -641,000.00 |
| Sep 30, 2021 | -437,000.00 |
| Jun 30, 2021 | -101,000.00 |
| Mar 31, 2021 | -8,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Sep 30, 2020 | 103,000.00 |
| Jun 30, 2020 | -1,000.00 |
| Mar 31, 2020 | 22,000.00 |
API Access
Inmune Bio Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();